Articles written by Dylan Sammut:

FSD Pharma Acquires Prismic Pharmaceuticals

FSD Pharma Inc. (CSE: HUGE), a Canadian-based cannabis company, has acquired Prismic Pharmaceuticals Inc. a specialty pharmaceutical company focused on novel non-addictive prescription drugs for the treatment of pain, inflammation and neurological disorder. The transaction cost approximately $17.5 million, but FSD gains Prismic’s worldwide licensing rights to a patent-protected form of palmitoylethanolamide, which can increase the effectiveness while […]

Health Care M&A Deals, Week Ending April 26, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]

Deal Count Dropped in ‘Other Services,’ but Spending Shot Up

As we researched data across 13 sectors for our upcoming publication, The Healthcare M&A Report, First Quarter 2019, an interesting trend in the “Other Services” sector popped up. This sector includes areas ancillary healthcare services such as ambulatory surgery centers, urgent care clinics, contract research organizations (CROs), healthcare staffing companies, specialty pharmacies, among others. Since it […]

Health Care M&A Deals, Week Ending April 19, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]

Ocugen Acquires Histogenics Corporation

Ocugen, Inc., a privately held clinical-stage biopharmaceutical company, has acquired Histogenics Corporation (NASDAQ: HSGX). Although no financial terms were disclosed, the merged company will be publicly-traded, operating under the Ocugen name. Ocugen discovers, develops and commercializes a pipeline of innovative therapies that address rare and underserved eye diseases. Histogenics develops a restorative cell therapy technology platform. It has collaborated with Brigham […]

Health Care M&A Deals, Week Ending April 12, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]

Small World: The Week of International Pharma Deals

Last week, the list of pharmaceutical deals announced also could have served as a geography lesson. Not only was the volume of deals particularly high, accounting for nearly 28% of the week’s total, but it had a diverse list of countries. Beginning in the United States, New York City-based Royalty Pharma, which focuses entirely on acquiring royalty interests […]

Advantia Health Jumps into Digital Health

Advantia Health, a physician medical group focused on women’s health, has acquired telehealth company Pacify. The target developed an app that offers virtual perinatal care for new and expectant mothers. It connects them with consultants and registered nurses to complement in-person visits with OB-GYNs, pediatricians and other physicians. The financial terms of the were not disclosed, […]

PE Firms Growing Influence in eHealth

In our 2019 Health Care Services Acquisition Report, Twenty-Fifth Edition, we reported how private equity firms have reshaped healthcare M&A on the services side. However, PE firms and their portfolio companies are also molding the tech sector, particularly in eHealth. In 2017, private equity firms and their portfolio companies accounted for roughly 29% of the 164 […]

Alacare Acquired by Encompass Health Corp.

Encompass Health Corp. (NYSE: EHC) announced it will acquire Alacare Home Health & Hospice for $217 million dollars. That purchase price was about 1.9x the target’s approximate 2018 revenue of $117 million. Founded in 1970, Alacare provides home health, hospice and palliative care, physical rehabilitation, and specialty programs for dementia, cancer, stroke and heart patients. It […]